Navigation Links
Cypak Compliancy Connection Powers Stora Enso Pharma DDSi
Date:11/20/2007

STOCKHOLM, November 20 /PRNewswire/ -- Stora Enso, a leading producer of pharmaceutical packaging boards, has launched Pharma DDSi , the first intelligent pharmaceutical packaging solution to use Cypak's Compliancy Connection.

Compliancy Connection is a standard low-cost electronic module built around a single RFID microchip and is designed to be embedded in pharmaceutical packaging. Electronic sensors are printed onto the packaging to detect when a dose of medicine is removed.

Non-compliance is increasingly recognized as a major problem in health care. Experts believe that over 50% of people do not take their medication as prescribed, causing tens of thousands of avoidable admissions to hospitals and care homes.

There are many reasons for non-compliancy. Memory lapses result in people skipping a dose or even taking multiple doses. Some people worry about side-effects, others misinterpret the instructions on how to take the medication. Sometimes children take medicines that are not intended for them, and older people struggle to open the packaging. Lack of objective compliancy data may even cause doctors to switch medication or increase dosage levels unnecessarily.

Pharma DDSi is a holistic solution that improves compliancy, providing objective data to caregivers and patients alike:

- Electronics embedded in the package provide reminders, record medication events, and transmit the medication history to the care-giver.

- A printed questionnaire captures the patient's feelings when taking medication. Direct communication to a specialist warns of side-effects and enables early intervention.

- DDSi is a carton solution. Clear instructions for use are printed on the packaging.

- Stora Enso also offers child resistant and senior friendly packaging solutions.

Pharma DDSi works with a variety of database solutions including PackAgent Compliance Monitoring software. This system is used for tracking and tracing the packages, capturing the compliance data and sharing results.

Per Nathanaelson, Cypak CEO, comments: "The low-cost electronic solution provided by Cypak, combined with Stora Enso's expertise, is further opening the way for widespread global adoption of intelligent pharmaceutical packaging."

Ismo Saarinen, Director, Pharmaceutical Solutions, Stora Enso, comments: "Pharma DDSi is a ground breaking solution. Together with Cypak we will continue to drive innovation, affordability, and connectivity."

Links: http://www.cypak.com and http://www.storaenso.com/pharma


'/>"/>
SOURCE Cypak AB
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. NIH awards $10.8M to Columbia to study connection between diabetes and heart disease
3. Vitasoy Promotes the Soy Breast Health Connection
4. Randy Jackson and the American Heart Association Promote Awareness about the Connection Between Type 2 Diabetes and Cardiovascular Disease
5. Research examines connection between substance abuse and violence
6. Bestselling Author Dr. Timothy Brantley Explains the Connection of Food and Mood
7. Study finds no connection between vitamin D and overall cancer deaths
8. Free Seminar Features State Funds Back Connection(TM), November 14, in Chico
9. Free Seminar Presents State Funds Back Connection(TM), November 13, in Redding
10. Hormonal Changes and Depression: What is the Connection?
11. Health Knowledge Empowers the Public
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... ... Despite its pervasiveness, many physicians are unfamiliar with how best to treat ... practice. Now, however, a timely review has been published in the Journal of ... NeuP and educating preclinical scientists on its diagnosis and choice of treatment. , The ...
(Date:6/20/2017)... Murfreesboro, Tennessee (PRWEB) , ... June 20, 2017 ... ... chronic care services, announced today that Claritas Capital, a Nashville-based private equity firm, ... to accelerate our expansion plans for some time, and Claritas Capital offers the ...
(Date:6/20/2017)... ... June 20, 2017 , ... Hayes, Inc., ... a new eBook titled “ 5 Questions to Ask Before Entering the Maze ... the Genetic Test Evaluation (GTE) team, the book explores the various types of ...
(Date:6/20/2017)... ... 20, 2017 , ... AMC Health , the leading provider of proven ... trials market. Similar to its approach in demonstrating positive outcomes in the healthcare market, ... proving the value of eVisits to support virtual studies. , In a ...
(Date:6/20/2017)... ... June 20, 2017 , ... With certifications and experience that puts ... NJ, Drs. Adam and Hal Kimowitz are currently accepting new patients at their practice ... can cause for some patients, which is why they offer the latest in modern ...
Breaking Medicine News(10 mins):
(Date:6/1/2017)... 2017 Nutriceutical Holdings (NH), parent company of ... and KD Pharma Group have decided to join forces ... Pharma Group. KD Pharma Group will become the largest ... the entire company. "We believe we have ... to growing the NH companies by providing us with ...
(Date:5/29/2017)... TEL AVIV, Israel, May 29, 2017  Cellect Biotechnology ... of innovative technology which enables the functional selection of ... financial results for the first quarter ended March 31 ... pleased with our accomplishments in the first quarter of ... the first quarter, we announced the treatment of the ...
(Date:5/23/2017)... 23, 2017  Leaf Healthcare, recognized for developing ... for pressure ulcer prevention, will unveil its comprehensive ... Critical Care Nurses, National Teaching Institute and Critical ... The Leaf Patient Monitoring System is the first ... environment.  The system seamlessly tracks patient movement throughout ...
Breaking Medicine Technology: